China Launches New Probe Into Pharma Corruption; Novartis AG (NVS) Accused of Bribery
8/15/2013 9:01:18 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
August 14, 2013 -- On Thursday, China’s State Administration for Industry and Commerce (SAIC) will begin a new three-month investigation to root out bribery in China’s pharmaceutical and medical services industries. The announcement came as a former drug salesperson charged that Novartis paid doctors to prescribe its products. More details....
Stock Symbol: (NYSE: NVS)
Help employers find you! Check out all the jobs and post your resume.
comments powered by